Research Use Only — Not for Human Consumption. This compound is sold exclusively for in vitro laboratory research by qualified professionals.
TIRZ-60
Tirzepatide 60 mg
Tirzepatide is a 39-amino acid synthetic peptide that functions as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. The 60 mg format is intended for bulk research protocols and chronic study designs requiring larger total compound quantities. Preclinical and clinical literature has extensively characterized its effects on insulin secretion, gastric emptying, glucagon suppression, and adipose tissue metabolism. Its unique dual-agonism mechanism differentiates it from selective GLP-1 analogues, offering researchers a tool to investigate the additive and synergistic contributions of both incretin axes. For research use only — not for human consumption.
Third-Party Tested. Every Lot.
Every batch of TIRZ-60 undergoes independent HPLC and mass spectrometry analysis through an accredited third-party laboratory before it is released for sale. No exceptions. No internal-only certificates.
RP-HPLC Analysis
Every lot measured by reverse-phase HPLC. TIRZ-60 consistently achieves 99.1%+ purity across batches.
ESI Mass Spec
Electrospray ionization mass spectrometry confirms exact molecular weight and rules out structural isomers or impurities.
Lot-Specific CoA
Your Certificate of Analysis references your exact lot number with actual chromatogram data — not a generic template.
Theoretical Research Analysis
All research information below reflects published preclinical literature only. This product is not for human use, consumption, or clinical application of any kind.
Tirzepatide has produced some of the most significant efficacy data in the metabolic peptide literature. Research has consistently demonstrated superior glucose-lowering and body weight reduction compared to selective GLP-1 agonists in head-to-head animal models, providing compelling evidence for the additive value of dual receptor engagement.
Sequence Information
Amino acid sequence:
Y-Aib-EGTFTSDYSIALDK(C₁₈ diacid)AQAAK(GIP motif)EFIAWLVKGRMolecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.46 g/mol
You May Also Like
View allTIRZ-30
Tirzepatide 30 mg
TIRZ-10
Tirzepatide 10 mg
Semaglutide 20mg
Semaglutide 20 mg — GLP-1 Agonist
SEMA-10
Semaglutide 10 mg